Zenopsis Pharmaceuticals Private Limited
About Zenopsis Pharmaceuticals Private Limited
Data last updated:
Zenopsis Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2016PTC085727. Its GSTIN is 09AAACZ9915E1Z1 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saurabh Kumar Sharma and Neetesh Rai Srivastava.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Bakkha Khera Mohanlal Ganj, Lucknow, Uttar Pradesh, India – 229001.
As per the financials filed for FY 2020, the company reported a revenue of ₹10.64 Lakh, a growth of 63% compared to the previous year. For the same year it recorded a net profit of ₹9,956 (net margin 0.9%) and EBITDA of ₹18,692 (EBITDA margin 1.8%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zenopsis Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBakkha Khera Mohanlal Ganj, Lucknow, Uttar Pradesh, India – 229001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zenopsis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zenopsis Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Zenopsis Pharmaceuticals Private Limited, buy the company report.
Financials of Zenopsis Pharmaceuticals Private Limited
FY 2020 filings availableZenopsis Pharmaceuticals Private Limited reported revenue of ₹10.64 Lakh (up 63% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 63% in the latest year. EBITDA fell 22% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹10.64 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹18,692 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹9,956 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.8% | |||
| Net Profit Margin | 0.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Zenopsis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zenopsis Pharmaceuticals Private Limited
Zenopsis Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Kumar Sharma | Director | 19 Aug 2016 | 10 Years 2 Months | Current |
| Neetesh Rai Srivastava | Director | 19 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Zenopsis Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zenopsis Pharmaceuticals Private Limitedthis company | ₹10.64 Lakh (FY 2020) | ₹9,956 | 0.9% | 63.0% | Lucknow, Uttar Pradesh, India | |
| Anise Pharmaceuticals Private Limited | ₹10.63 Lakh (FY 2025) | -13.0% | Delhi, India | |||
| Aglaea Pharmaceuticals Private Limited | ₹10.63 Lakh (FY 2021) | 450.0% | New Delhi, Delhi, India | |||
| Yestomo Pharmaceuticals Private Limited | ₹10.62 Lakh (FY 2024) | 33.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Zenopsis Pharmaceuticals Private Limited, buy the company report.
Auditor
Zenopsis Pharmaceuticals Private Limited is audited by SHARAD SRIVASTAVA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHARAD SRIVASTAVA & CO | FY 2019 | 011449C |
Shareholding
The shareholding of Zenopsis Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Zenopsis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zenopsis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zenopsis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zenopsis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACZ9915E1Z1 | Uttar Pradesh | Active | 16 Jan 2018 |
To see the full GST registrations and return filing status of Zenopsis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zenopsis Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Mahendra Kumar Sharma ceased to be Director on 01 Jan 2019.
Frequently asked questions
Zenopsis Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 August 2016 (10+ years old) and is registered under CIN U74999UP2016PTC085727.
Zenopsis Pharmaceuticals has 2 current directors:
- Saurabh Kumar Sharma - Director
- Neetesh Rai Srivastava - Director
The latest financial statements of Zenopsis Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Zenopsis Pharmaceuticals is 09AAACZ9915E1Z1, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Zenopsis Pharmaceuticals is U74999UP2016PTC085727. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zenopsis Pharmaceuticals was incorporated on 19 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Zenopsis Pharmaceuticals by revenue are Anise Pharmaceuticals Private Limited, Aglaea Pharmaceuticals Private Limited, Yestomo Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (retail trading).
Mahendra Kumar Sharma ceased to be Director on 01 Jan 2019. Sachin Dixit ceased to be Director on 01 Jan 2019. Neetesh Rai Srivastava was appointed as Director on 19 Aug 2016. Zenopsis Pharmaceuticals has 4 board changes on record in total.
The registered office of Zenopsis Pharmaceuticals is at Bakkha Khera Mohanlal Ganj, Lucknow, Uttar Pradesh, India – 229001.
Zenopsis Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Zenopsis Pharmaceuticals is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
